Ex-My­lan em­ploy­ee pleads guilty to in­sid­er trad­ing, il­le­gal­ly deal­ing on FDA ap­provals, earn­ings and Up­john merg­er

A for­mer My­lan IT ex­ec­u­tive plead­ed guilty Fri­day to an in­sid­er trad­ing scheme where he bought and sold stock op­tions on an­oth­er ex­ec­u­tive’s ad­vice.

Pros­e­cu­tors se­cured the plea from Dayakar Mal­lu, My­lan’s for­mer VP of glob­al op­er­a­tions in­for­ma­tion tech­nol­o­gy, af­ter un­cov­er­ing the plan. Mal­lu col­lab­o­rat­ed with an un­named “se­nior man­ag­er,” the SEC said, to trade op­tions ahead of My­lan pub­lic an­nounce­ments re­gard­ing FDA ap­provals, rev­enue re­ports and its merg­er with the Pfiz­er gener­ics sub­sidiary Up­john. The two sub­se­quent­ly shared prof­its.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER